Unibest 优贝德
← Back to patent-cliff list

CAS 110-85-0

piperazine哌嗪无水哌嗪六氢吡嗪1,4-Diazacyclohexane

Codes:PALB-042、OLAP-013、RIBO-012、BREX-006、VORT-004、RANO-004、POSA-037

Physicochemical properties & identification

Formula
C4H10N2
Mol. weight
86.14
Appearance
白色至无色结晶或片块,强吸湿,有胺味
Melting point
106 – 108 °C
Boiling point
146 °C
Solubility
极易溶于水、乙醇;强碱(pKa1 ≈ 5.6 / pKa2 ≈ 9.8)
Storage
密封充氮避潮;远离酸类与氧化剂

Applications

  • · 药物砌块:阿立哌唑/布瑞哌唑/卡利拉嗪等含哌嗪环 CNS 药物的核心胺源
  • · 驱虫药哌嗪盐(柠檬酸盐/磷酸盐)原料
  • · CO2 捕收(MDEA 配方活化剂)、环氧固化剂

Application context (from source-drug indications)

乳腺癌哌柏西利子宫内膜癌奥拉帕利去势抵抗性前列腺肿瘤奥拉帕利前列腺癌奥拉帕利腹膜癌奥拉帕利卵巢上皮癌奥拉帕利输卵管癌奥拉帕利乳腺癌琥珀酸瑞波西利精神分裂症布瑞哌唑阿尔茨海默病布瑞哌唑躁动布瑞哌唑抑郁布瑞哌唑抑郁症布瑞哌唑重度抑郁症布瑞哌唑重度抑郁症氢溴酸伏硫西汀术后疼痛氢溴酸伏硫西汀大麻依赖氢溴酸伏硫西汀焦虑氢溴酸伏硫西汀焦虑症氢溴酸伏硫西汀抑郁氢溴酸伏硫西汀心绞痛雷诺嗪心肌梗塞雷诺嗪肌萎缩性侧索硬化雷诺嗪稳定型心绞痛雷诺嗪克罗恩病雷诺嗪炎症性肠疾病雷诺嗪念珠菌病泊沙康唑曲霉菌属感染泊沙康唑真菌感染泊沙康唑口腔念珠菌病泊沙康唑球孢菌病泊沙康唑组织胞浆菌病泊沙康唑

Source drugs (routes using this intermediate)

DrugTierExpiry
哌柏西利PalbociclibTier A — Act now2027
奥拉帕利OlaparibTier A — Act now2028
琥珀酸瑞波西利Ribociclib SuccinateTier A — Act now2029
布瑞哌唑BrexpiprazoleTier A — Act now2029
氢溴酸伏硫西汀Vortioxetine HydrobromideTier B — Position early-
雷诺嗪RanolazineTier C — Watch / trade-
泊沙康唑PosaconazoleTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

布瑞哌唑原研路线steps: 3total yield: 13.6 g
7-hydroxyquinolin-2(1H)-one→1-bromo-4-chlorobutane→7-(4-chlorobutoxy)quinolin-2(1H)-one→1-(benzo[b]thiophen-4-yl)piperazine hydrochloride→4-bromobenzo[b]thiophene→piperazine
氢溴酸伏硫西汀原研路线steps: 5total yield: 13.3 g
1,2-dichlorobenzene→VORT-002→VORT-003→piperazine→VORT-005→2,4-dimethylbenzenethiol→VORT-007

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Unibest Nantong cGMP Site2-Fluoro-5-formylbenzonitrile
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]benzonitrile
Pharmaceutical Intermediates
询价询价询价
—
Qualified Partner — East China API Works2-fluoro-5-((4-oxo-3,4-dihydrophthalazin -1-yl)Methyl)benzoic acid
Pharmaceutical Intermediates
询价询价询价
—
Unibest Nantong cGMP Site1-(Cyclopropylcarbonyl)piperazine hydrochloride
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid
Pharmaceutical Intermediates
询价询价询价
—
Qualified Partner — East China API Works5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine
Pharmaceutical Intermediates
询价询价询价
—
Unibest Nantong cGMP Site2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Pharmaceutical Intermediates
询价询价询价
—
Qualified Partner — East China API Workstert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
询价询价询价
—
Unibest Nantong cGMP SiteTert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Sitetert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
询价询价询价
—
Qualified Partner — East China API WorksPD 0332991 HCl
Pharmaceutical Intermediates
询价询价询价
—
Unibest Nantong cGMP Site2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6- carboxamide
Pharmaceutical Intermediates
询价询价询价
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.